We work with our clients to develop and implement testing approaches that integrate animal disease models and human tissue assays.
We can apply our animal models and standardised assays for human peripheral blood analysis, pharmacodynamics and pharmacokinetics.
Our leadership and advisory teams are trusted, world-renowned experts in a range of fields, with combined expertise in immunology, endocrinology, animal models of diabetes and genomics. We have a proven track record in clinical translation, which encompasses onsite human islet isolation and transplantation, biobanking and clinical trials.
Effica Biolabs is listed on the Therapeutic Innovation Australia (TIA) Pipeline Navigator.
We see ourselves as more than service providers. We are your partners – treating your projects as if they were our own. We work with you to design experiments that will deliver valuable insights and reach critical milestones on time and on budget.
Effica Biolabs has close networks with other recommended service providers with whom we can partner to complement and expand your experimental design and testing needs.We test
Our team has a depth of experience testing different types of therapeutics in animal models and human tissue. Our established suite of models, assays and data analysis expertise, in combination with state-of-the-art facilities and technology platforms, means we can offer both proof-of-concept and larger, more complex experiments to test your therapies.We deliver
Through a collaborative, seamless process, we generate data to address your specific requirements. We provide reliable results that will help identify the best ‘next step’ for your project – whether that be scientific publications, clinical trials or regulatory submissions.Effica Biolabs team members
Prof Helen Thomas, BSc (Hons), PhD Scientific Director
Dr Tom Brodnicki, BSc, PhD Operations & Project Manager
Prof Tom Kay, BMedSci, MBBS, PhD, FRACP, FRCPA
A/Prof Stuart Mannering, BSc, MSc, PhD
Dr Tom Loudovaris, BSc (Hons), PhD
Dr Michaela Waibel, PhD